Molecular alterations and targeted therapy in pancreatic ductal adenocarcinoma

Y Qian, Y Gong, Z Fan, G Luo, Q Huang… - Journal of hematology & …, 2020 - Springer
Pancreatic ductal adenocarcinoma (PDAC) is a malignancy characterized by a poor
prognosis and high mortality rate. Genetic mutations and altered molecular pathways serve …

Current perspectives on the immunosuppressive tumor microenvironment in hepatocellular carcinoma: challenges and opportunities

C Lu, D Rong, B Zhang, W Zheng, X Wang, Z Chen… - Molecular cancer, 2019 - Springer
Incidence of hepatocellular carcinoma (HCC) is on the rise due to the prevalence of chronic
hepatitis and cirrhosis. Although there are surgical and chemotherapy treatment avenues …

[HTML][HTML] Integrated proteogenomic characterization of HBV-related hepatocellular carcinoma

Q Gao, H Zhu, L Dong, W Shi, R Chen, Z Song… - Cell, 2019 - cell.com
We performed the first proteogenomic characterization of hepatitis B virus (HBV)-related
hepatocellular carcinoma (HCC) using paired tumor and adjacent liver tissues from 159 …

Stromal gene expression defines poor-prognosis subtypes in colorectal cancer

A Calon, E Lonardo, A Berenguer-Llergo, E Espinet… - Nature …, 2015 - nature.com
Recent molecular classifications of colorectal cancer (CRC) based on global gene
expression profiles have defined subtypes displaying resistance to therapy and poor …

TGF‐β signalling and liver disease

I Fabregat, J Moreno‐Càceres, A Sánchez… - The FEBS …, 2016 - Wiley Online Library
The transforming growth factor‐beta (TGF‐β) family signalling pathways play essential roles
in the regulation of different cellular processes, including proliferation, differentiation …

Role of epithelial to mesenchymal transition in hepatocellular carcinoma

G Giannelli, P Koudelkova, F Dituri, W Mikulits - Journal of hepatology, 2016 - Elsevier
The epithelial to mesenchymal transition (EMT) is a multistep biological process whereby
epithelial cells change in plasticity by transient de-differentiation into a mesenchymal …

Advances in targeted therapies for hepatocellular carcinoma in the genomic era

JM Llovet, A Villanueva, A Lachenmayer… - Nature reviews Clinical …, 2015 - nature.com
Mortality owing to liver cancer has increased in the past 20 years, and the latest estimates
indicate that the global health burden of this disease will continue to grow. Most patients with …

Clinical development of galunisertib (LY2157299 monohydrate), a small molecule inhibitor of transforming growth factor-beta signaling pathway

S Herbertz, JS Sawyer, AJ Stauber… - Drug design …, 2015 - Taylor & Francis
Transforming growth factor-beta (TGF-β) signaling regulates a wide range of biological
processes. TGF-β plays an important role in tumorigenesis and contributes to the hallmarks …

EMT: 2016

MA Nieto, RYJ Huang, RA Jackson, JP Thiery - cell, 2016 - cell.com
The significant parallels between cell plasticity during embryonic development and
carcinoma progression have helped us understand the importance of the epithelial …

The basics of epithelial–mesenchymal transition (EMT): A study from a structure, dynamics, and functional perspective

V Das, S Bhattacharya… - Journal of cellular …, 2019 - Wiley Online Library
Epithelial–mesenchymal transition (EMT) is a key step in transdifferentiation process in solid
cancer development. Forthcoming evidence suggest that the stratified program transforms …